COMMUNIQUÉS West-GlobeNewswire

Portola Pharmaceuticals to Host Webcast Event and Conference Call at ACC.18 to Discuss Late-Breaking Oral Presentation Highlighting New Interim Data for Andexanet Alfa
05/03/2018
SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA ) today announced that it will host a live audio webcast and conference call on Monday, March 12, 2018 at the [...]
GBT Announces Participation at Upcoming Investor Conferences in March
05/03/2018
SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that it will present at the following investor conferences in March 2018: Cowen and [...]
Kura Oncology to Report Fourth Quarter and Full Year 2017 Financial Results
05/03/2018
SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it will [...]
Anthera Pharmaceuticals Provides Business Update and Reports 2017 Fourth Quarter and Fiscal Year Financial Results
05/03/2018
RESULT study reported positive interim futility analyses and completion of dosing, with top line data expected in March 2018 Completed private placement for net proceeds of $13.3 million Received net proceeds of $3.1 [...]
Aeterna Zentaris Appoints James Clavijo as Chief Financial Officer
05/03/2018
CHARLESTON, S.C., March 05, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) today announced the appointment of James Clavijo as Chief Financial Officer effective March 5, 2018. Mr. Clavijo [...]
Aduro Announces Milestone Achieved under Merck Collaboration for Initiation of Anti-CD27 Phase I Trial in Advanced Solid Tumors
05/03/2018
BERKELEY, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today announced that the company earned a $3.0 million development milestone payment under its worldwide licensing agreement with [...]
Ovid Therapeutics to Present at Two Upcoming Investor Conferences
05/03/2018
NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines for patients with rare neurological disorders, today announced that [...]
GBT Announces New Employment Inducement Grants
05/03/2018
SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT or the Company) (NASDAQ: GBT ) today announced that on March 1, 2018, the compensation committee of the Company’s [...]
Alder BioPharmaceuticals® to Present at 38th Annual Cowen & Co. Health Care Conference
05/03/2018
BOTHELL, Wash., March 05, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Joseph Darling Named CEO and Director of Anika Therapeutics
05/03/2018
BEDFORD, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK ) today announced the appointment of Joseph Darling as Chief Executive Officer, succeeding Dr. Charles Sherwood, who will retire [...]
Catalyst Biosciences Announces the Calling of Remaining Warrants and Conversion of Remaining Series A Preferred Shares Issued April 12, 2017
05/03/2018
Total of 11.9 million common shares outstanding post-conversion and warrant exercise SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq: CBIO ), a clinical-stage [...]
Endocyte to Present at the Cowen and Company 38th Annual Health Care Conference
05/03/2018
WEST LAFAYETTE, March 05, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment , today announced that the company’s [...]
Spring Bank Pharmaceuticals Appoints Timothy Clackson, Ph.D., to its Board of Directors
05/03/2018
Spring Bank strengthens Board of Directors with the addition of a prominent biopharma R&D veteran HOPKINTON, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH ), a clinical- [...]
Aduro Biotech Appoints Hans van Eenennaam Executive Vice President Antibody Research and Site Head, Aduro Biotech Europe
05/03/2018
BERKELEY, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today announced that Hans van Eenennaam, Ph.D. has been promoted to executive vice president antibody research and site head of [...]
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2018
05/03/2018
RANCHO CUCAMONGA, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) announced that the Company will release results for its fourth quarter of 2017 ended December 31, 2017, after [...]
Maple Leaf Provides Update on its Telkwa, British Columbia Facility
05/03/2018
CALGARY, Alberta, March 05, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (TSXV:MGW) (OTCQB:MGWFF) is pleased to announce it has received a progress report from the Company’s [...]
Cytokinetics to Present at March Investor Conferences
05/03/2018
SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate [...]
Galectin Therapeutics Announces Record Date and Annual Stockholders Meeting Date for 2018
05/03/2018
NORCROSS, Ga., March 05, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today announced March 26, 2018 is the record date for [...]
OpGen Announces Date of Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call
05/03/2018
GAITHERSBURG, Md., March 05, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announced today that the Company will report its fourth quarter and fiscal year 2017 financial results after close of market on Thursday [...]

Pages